{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:04:47Z","timestamp":1768349087131,"version":"3.49.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10096-025-05114-8","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:25:18Z","timestamp":1746170718000},"page":"1779-1796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Complicated pneumococcal pneumonia in the era of higher-valent pneumococcal conjugate vaccines: a systematic literature review and meta-analysis, 2001\u20132022"],"prefix":"10.1007","volume":"44","author":[{"given":"Mark A.","family":"Fletcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Okasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Baay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Syrochkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyla","family":"Hayford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"issue":"11","key":"5114_CR1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","volume":"17","author":"GL Collaborators","year":"2017","unstructured":"Collaborators GL (2017) Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis 17(11):1133\u20131161","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"5114_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s10096-014-2062-6","volume":"33","author":"MA Fletcher","year":"2014","unstructured":"Fletcher MA, Schmitt H-J, Syrochkina M, Sylvester G (2014) Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 33(6):879\u2013910","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology"},{"issue":"4","key":"5114_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jinf.2015.06.011","volume":"71","author":"S Saxena","year":"2015","unstructured":"Saxena S, Atchison C, Cecil E, Sharland M, Koshy E, Bottle A (2015) Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England. J Infect 71(4):428\u2013436","journal-title":"J Infect"},{"key":"5114_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s13665-017-0161-4","volume":"6","author":"M Zampoli","year":"2017","unstructured":"Zampoli M, Chaya S, Zar HJ (2017) Empyema in Children: Update of Aetiology, Diagnosis and Management Approaches. Current Pulmonology Reports 6:16\u201325","journal-title":"Current Pulmonology Reports"},{"issue":"21","key":"5114_CR5","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1016\/j.vaccine.2018.04.032","volume":"36","author":"TJ Marrie","year":"2018","unstructured":"Marrie TJ, Tyrrell GJ, Majumdar SR, Eurich DT (2018) Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse. Vaccine 36(21):2985\u20132990","journal-title":"Vaccine"},{"issue":"7","key":"5114_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","volume":"25","author":"JG Liese","year":"2019","unstructured":"Liese JG, Schoen C, van der Linden M, Lehmann L, Goettler D, Keller S, Maier A, Segerer F, Rose MA, Streng A (2019) Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010\u20132017: a nationwide surveillance study. Clin Microbiol Infect 25(7):857\u2013864","journal-title":"Clin Microbiol Infect"},{"key":"5114_CR7","doi-asserted-by":"crossref","unstructured":"Wiese AD, Griffin MR, Zhu Y, Mitchel EF, Jr., Grijalva CG (2016) Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era. Vaccine 34 (50):6243\u20136249","DOI":"10.1016\/j.vaccine.2016.10.062"},{"issue":"7","key":"5114_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097","journal-title":"PLoS Med"},{"key":"5114_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5:210","journal-title":"Syst Rev"},{"key":"5114_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hr\u00f3bjartsson A, Kirkham J, J\u00fcni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch\u00fcnemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"key":"5114_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743386","volume-title":"Introduction to Meta-Analysis","author":"M Borenstein","year":"2009","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to Meta-Analysis. John Wiley & Sons"},{"key":"5114_CR12","unstructured":"Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2021) Cochrane Handbook for Systematic Reviews of Interventions. Cochrane"},{"issue":"17","key":"5114_CR13","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/sim.1482","volume":"22","author":"G Knapp","year":"2003","unstructured":"Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22(17):2693\u20132710","journal-title":"Stat Med"},{"issue":"3","key":"5114_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W (2010) Conducting Meta-Analyses in R with the metafor Package. J Stat Softw 36(3):1\u201348","journal-title":"J Stat Softw"},{"issue":"6","key":"5114_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/INF.0b013e31827e8594","volume":"32","author":"J Picazo","year":"2013","unstructured":"Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Garcia-de-Miguel MJ, Hernandez-Sampelayo T, Otheo E, Mendez C (2013) Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011. Pediatr Infect Dis J 32(6):656\u2013661","journal-title":"Pediatr Infect Dis J"},{"issue":"20","key":"5114_CR16","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1016\/j.vaccine.2019.04.012","volume":"37","author":"C Azzari","year":"2019","unstructured":"Azzari C, Serranti D, Nieddu F, Moriondo M, Casini A, Lodi L, de Benedictis FM, De Vitis E, Cavone F, Cortimiglia M, Indolfi G, Lombardi E, Carloni I, Cutrera R, Lucenteforte E, Resti M, Ricci S (2019) Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006\u20132018. Vaccine 37(20):2704\u20132711","journal-title":"Vaccine"},{"issue":"3","key":"5114_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/cid\/cir354","volume":"53","author":"J Burgos","year":"2011","unstructured":"Burgos J, Lujan M, Falco V, Sanchez A, Puig M, Borrego A, Fontanals D, Planes AM, Pahissa A, Rello J (2011) The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis 53(3):254\u2013261","journal-title":"Clin Infect Dis"},{"issue":"8","key":"5114_CR18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.vaccine.2015.12.066","volume":"34","author":"GH Wagenvoort","year":"2016","unstructured":"Wagenvoort GH, Sanders EA, Vlaminckx BJ, Elberse KE, de Melker HE, van der Ende A, Knol MJ (2016) Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2\u20136 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands. Vaccine 34(8):1077\u20131085","journal-title":"Vaccine"},{"issue":"6","key":"5114_CR19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/650573","volume":"50","author":"CG Grijalva","year":"2010","unstructured":"Grijalva CG, Nuorti JP, Zhu Y, Griffin MR (2010) Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis 50(6):805\u2013813","journal-title":"Clin Infect Dis"},{"issue":"9","key":"5114_CR20","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/j.1651-2227.2011.02290.x","volume":"100","author":"E Niemi","year":"2011","unstructured":"Niemi E, Korppi M (2011) Parapneumonic empyema in children before the era of pneumococcal vaccination. Acta Paediatr 100(9):1230\u20131233","journal-title":"Acta Paediatr"},{"issue":"7","key":"5114_CR21","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1128\/CVI.00765-12","volume":"20","author":"M Ceyhan","year":"2013","unstructured":"Ceyhan M, Ozsurekci Y, Gurler N, Ozkan S, Sensoy G, Belet N, Hacimustafaoglu M, Celebi S, Keser M, Dinleyici EC, Alhan E, Baki A, Oner AF, Uzun H, Kurugol Z, Aycan AE, Gurbuz V, Karadag Oncel E, Celik M, Ozkaya Parlakay A (2013) Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey. Clin Vaccine Immunol 20(7):972\u2013976","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"5114_CR22","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00431-014-2319-1","volume":"173","author":"M Proesmans","year":"2014","unstructured":"Proesmans M, Gijsens B, Van de Wijdeven P, De Caluwe H, Verhaegen J, Lagrou K, Van Even E, Vermeulen F, De Boeck K (2014) Clinical outcome of parapneumonic empyema in children treated according to a standardized medical treatment. Eur J Pediatr 173(10):1339\u20131345","journal-title":"Eur J Pediatr"},{"issue":"1","key":"5114_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/apa.12426","volume":"103","author":"D Yu","year":"2014","unstructured":"Yu D, Buchvald F, Brandt B, Nielsen KG (2014) Seventeen-year study shows rise in parapneumonic effusion and empyema with higher treatment failure after chest tube drainage. Acta Paediatr 103(1):93\u201399","journal-title":"Acta Paediatr"},{"key":"5114_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.rmed.2016.05.009","volume":"116","author":"K Krenke","year":"2016","unstructured":"Krenke K, Sadowy E, Podsiadly E, Hryniewicz W, Demkow U, Kulus M (2016) Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests. Respir Med 116:28\u201333","journal-title":"Respir Med"},{"issue":"6","key":"5114_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/jpc.13172","volume":"52","author":"C Mahon","year":"2016","unstructured":"Mahon C, Walker W, Drage A, Best E (2016) Incidence, aetiology and outcome of pleural empyema and parapneumonic effusion from 1998 to 2012 in a population of New Zealand children. J Paediatr Child Health 52(6):662\u2013668","journal-title":"J Paediatr Child Health"},{"issue":"10","key":"5114_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/23744235.2016.1192720","volume":"48","author":"GA Syrogiannopoulos","year":"2016","unstructured":"Syrogiannopoulos GA, Michoula AN, Tsimitselis G, Vassiou K, Chryssanthopoulou DC, Grivea IN (2016) Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine. Infect Dis (Lond) 48(10):749\u2013753","journal-title":"Infect Dis (Lond)"},{"issue":"5","key":"5114_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ppul.24279","volume":"54","author":"A Diaz-Conradi","year":"2019","unstructured":"Diaz-Conradi A, Hernandez S, Garcia-Garcia JJ, Munoz-Almagro C, Moraga-Llop F, Ciruela P, Izquierdo C, Campins M, de Sevilla MF, Gonzalez-Peris S, Uriona S, Martinez-Osorio J, Sole-Ribalta A, Codina G, Esteva C, Planes AM, Soldevila N, Salleras L, Dominguez A (2019) Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era. Pediatr Pulmonol 54(5):517\u2013524","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"5114_CR28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/ppul.20434","volume":"41","author":"N Ramphul","year":"2006","unstructured":"Ramphul N, Eastham KM, Freeman R, Eltringham G, Kearns AM, Leeming JP, Hasan A, Hamilton LJ, Spencer DA (2006) Cavitatory lung disease complicating empyema in children. Pediatr Pulmonol 41(8):750\u2013753","journal-title":"Pediatr Pulmonol"},{"key":"5114_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2334-8-90","volume":"8","author":"B Nyambat","year":"2008","unstructured":"Nyambat B, Kilgore PE, Yong DE, Anh DD, Chiu CH, Shen X, Jodar L, Ng TL, Bock HL, Hausdorff WP (2008) Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease. BMC Infect Dis 8:90","journal-title":"BMC Infect Dis"},{"issue":"9","key":"5114_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00431-010-1195-6","volume":"169","author":"TK Chibuk","year":"2010","unstructured":"Chibuk TK, Robinson JL, Hartfield DS (2010) Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7). Eur J Pediatr 169(9):1123\u20131128","journal-title":"Eur J Pediatr"},{"issue":"7","key":"5114_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ppul.23041","volume":"50","author":"MA Elemraid","year":"2015","unstructured":"Elemraid MA, Thomas MF, Blain AP, Rushton SP, Spencer DA, Gennery AR, Clark JE (2015) Risk factors for the development of pleural empyema in children. Pediatr Pulmonol 50(7):721\u2013726","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"5114_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/INF.0000000000000631","volume":"34","author":"YC Hsieh","year":"2015","unstructured":"Hsieh YC, Chi H, Chang KY, Lai SH, Mu JJ, Wong KS, Liu CC, Huang YC, Lin HC, Chang LY, Huang YC, Huang LM (2015) Increase in fitness of Streptococcus pneumoniae is associated with the severity of necrotizing pneumonia. Pediatr Infect Dis J 34(5):499\u2013505","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"5114_CR33","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1542\/peds.113.6.1735","volume":"113","author":"KD Schultz","year":"2004","unstructured":"Schultz KD, Fan LL, Pinsky J, Ochoa L, Smith EO, Kaplan SL, Brandt ML (2004) The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113(6):1735\u20131740","journal-title":"Pediatrics"},{"issue":"12","key":"5114_CR34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1097\/INF.0000000000000880","volume":"34","author":"M Zampoli","year":"2015","unstructured":"Zampoli M, Kappos A, Wolter N, von Gottberg A, Verwey C, Mamathuba R, Zar HJ (2015) Etiology and Incidence of Pleural Empyema in South African Children. Pediatr Infect Dis J 34(12):1305\u20131310","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"5114_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/jpids\/piw089","volume":"7","author":"EL Lopez","year":"2018","unstructured":"Lopez EL, Glatstein E, Ezcurra GC, Iacono M, Teplitz E, Garnero AV, Lazzarini DL, Vazquez M, Contrini MM (2018) Rapid Decrease in Rates of Hospitalization Resulting From Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Children Aged <60 Months After 13-Valent Pneumococcal Conjugate Vaccine Introduction in Argentina. J Pediatric Infect Dis Soc 7(1):30\u201335","journal-title":"J Pediatric Infect Dis Soc"},{"key":"5114_CR36","doi-asserted-by":"crossref","unstructured":"Madhi F, Levy C, Morin L, Minodier P, Dubos F, Zenkhri F, Dommergues MA, Mezgueldi E, Levieux K, Bechet S, Varon E, Cohen R (2018) Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation. J Pediatric Infect Dis Soc.\u00a08:474-477","DOI":"10.1093\/jpids\/piy103"},{"issue":"5","key":"5114_CR37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/thoraxjnl-2020-216032","volume":"76","author":"R Strachan","year":"2021","unstructured":"Strachan R, Homaira N, Beggs S, Bhuiyan MU, Gilbert GL, Lambert SB, Macartney K, Marshall H, Martin AC, McCallum GB, McCullagh A, McDonald T, McIntyre P, Oftadeh S, Ranganathan S, Suresh S, Wainwright CE, Wilson A, Wong M, Snelling T, Jaff\u00e9 A (2021) Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax 76(5):487\u2013493","journal-title":"Thorax"},{"issue":"12","key":"5114_CR38","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/cid\/cix115","volume":"64","author":"L Olarte","year":"2017","unstructured":"Olarte L, Barson WJ, Barson RM, Romero JR, Bradley JS, Tan TQ, Givner LB, Hoffman JA, Lin PL, Hulten KG, Mason EO, Kaplan SL (2017) Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clin Infect Dis 64(12):1699\u20131704","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5114_CR39","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1086\/381974","volume":"38","author":"YC Hsieh","year":"2004","unstructured":"Hsieh YC, Hsueh PR, Lu CY, Lee PI, Lee CY, Huang LM (2004) Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis 38(6):830\u2013835","journal-title":"Clin Infect Dis"},{"issue":"9","key":"5114_CR40","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1086\/656579","volume":"51","author":"M Resti","year":"2010","unstructured":"Resti M, Moriondo M, Cortimiglia M, Indolfi G, Canessa C, Becciolini L, Bartolini E, de Benedictis FM, de Martino M, Azzari C (2010) Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis 51(9):1042\u20131049","journal-title":"Clin Infect Dis"},{"issue":"7","key":"5114_CR41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/INF.0b013e31825384ae","volume":"31","author":"S Esposito","year":"2012","unstructured":"Esposito S, Marchese A, Tozzi AE, Rossi GA, Da Dalt L, Bona G, Pelucchi C, Schito GC, Principi N (2012) Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy. Pediatr Infect Dis J 31(7):705\u2013710","journal-title":"Pediatr Infect Dis J"},{"key":"5114_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12887-015-0387-7","volume":"15","author":"HJ Hsiao","year":"2015","unstructured":"Hsiao HJ, Wu CT, Huang JL, Chiu CH, Huang YC, Lin JJ, Huang IA, Chan OW, Chou IJ, Hsia SH (2015) Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit. BMC Pediatr 15:85","journal-title":"BMC Pediatr"},{"key":"5114_CR43","doi-asserted-by":"crossref","unstructured":"Lee MC, Kuo KC (2019) The clinical implication of serotype distribution and drug resistance of invasive pneumococcal disease in children: A single center study in southern Taiwan during 2010\u20132016. J Microbiol Immunol Infect.\u00a052:937-946","DOI":"10.1016\/j.jmii.2019.04.006"},{"issue":"3","key":"5114_CR44","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1378\/chest.130.3.800","volume":"130","author":"X Valles","year":"2006","unstructured":"Valles X, Marcos A, Pinart M, Piner R, Marco F, Mensa JM, Torres A (2006) Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased? Chest 130(3):800\u2013806","journal-title":"Chest"},{"issue":"5","key":"5114_CR45","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1183\/09031936.00176309","volume":"36","author":"M Lujan","year":"2010","unstructured":"Lujan M, Gallego M, Belmonte Y, Fontanals D, Valles J, Lisboa T, Rello J (2010) Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia. Eur Respir J 36(5):1073\u20131079","journal-title":"Eur Respir J"},{"issue":"11","key":"5114_CR46","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/j.1469-0691.2011.03692.x","volume":"18","author":"C Cilloniz","year":"2012","unstructured":"Cilloniz C, Ewig S, Polverino E, Munoz-Almagro C, Marco F, Gabarrus A, Menendez R, Mensa J, Torres A (2012) Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes. Clin Microbiol Infect 18(11):1134\u20131142","journal-title":"Clin Microbiol Infect"},{"issue":"31","key":"5114_CR47","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1016\/j.vaccine.2014.04.089","volume":"32","author":"AJ Cremers","year":"2014","unstructured":"Cremers AJ, Meis JF, Walraven G, Jongh CE, Ferwerda G, Hermans PW (2014) Effects of 7-valent pneumococcal conjugate 1 vaccine on the severity of adult 2 bacteremic pneumococcal pneumonia. Vaccine 32(31):3989\u20133994","journal-title":"Vaccine"},{"issue":"15","key":"5114_CR48","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.vaccine.2016.01.038","volume":"34","author":"F Sanz-Herrero","year":"2016","unstructured":"Sanz-Herrero F, Gimeno-Cardona C, Tormo-Palop N, Fernandez-Fabrellas E, Briones ML, Cervera-Juan A, Blanquer-Olivas J (2016) The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired pneumonia. Vaccine 34(15):1847\u20131852","journal-title":"Vaccine"},{"issue":"1","key":"5114_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/23744235.2016.1218044","volume":"49","author":"A Payeras","year":"2017","unstructured":"Payeras A, Penaranda M, Inigo A, Garau M, Luis Perez J, Gallegos C, Riera M (2017) Pneumococcal infections in elderly patients attending hospital since PCV-13 authorization in Spain. Infect Dis (Lond) 49(1):71\u201380","journal-title":"Infect Dis (Lond)"},{"issue":"29","key":"5114_CR50","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1016\/j.vaccine.2019.05.052","volume":"37","author":"PP Espana","year":"2019","unstructured":"Espana PP, Uranga A, Ruiz LA, Quintana JM, Bilbao A, Aramburu A, Serrano L, Ayarza R, Martinez AP, Zalacain R (2019) Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the period 2001\u20132014, after introduction of the pneumococcal conjugate vaccine in bizkaia (spain). Vaccine 37(29):3840\u20133848","journal-title":"Vaccine"},{"issue":"1","key":"5114_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1086\/430604","volume":"41","author":"CL Byington","year":"2005","unstructured":"Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia AT (2005) Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 41(1):21\u201329","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5114_CR52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/INF.0b013e31823dcc72","volume":"31","author":"K Ampofo","year":"2012","unstructured":"Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL (2012) The changing epidemiology of invasive pneumococcal disease at a tertiary children\u2019s hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J 31(3):228\u2013234","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"5114_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1590\/S1516-31802004000600008","volume":"122","author":"LM Cirino","year":"2004","unstructured":"Cirino LM, Gomes FM, Batista BN (2004) The etiology of extensive pleural effusions with troublesome clinical course among children. Sao Paulo Med J 122(6):269\u2013272","journal-title":"Sao Paulo Med J"},{"issue":"2","key":"5114_CR54","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jinf.2011.06.002","volume":"63","author":"C Mu\u00f1oz-Almagro","year":"2011","unstructured":"Mu\u00f1oz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gall\u00e9s C, Morta M, Ballester F, Raga X, Selva L (2011) Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia. Spain Journal of Infection 63(2):151\u2013162","journal-title":"Spain Journal of Infection"},{"issue":"6","key":"5114_CR55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/INF.0b013e31820a418a","volume":"30","author":"J Picazo","year":"2011","unstructured":"Picazo J, Ruiz-Contreras J, Casado-Flores J, Negreira S, Del Castillo F, Hernandez-Sampelayo T, Bueno M, Calvo C, Rios E, Mendez C (2011) Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in Madrid. Pediatr Infect Dis J 30(6):471\u2013474","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"5114_CR56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.medcli.2013.07.023","volume":"143","author":"MT Perez-Rodriguez","year":"2014","unstructured":"Perez-Rodriguez MT, Sopena B, Mendez-Lage S, Casares Mde L, Constenla L, Argibay A, Nodar A, Villaverde I, Martinez-Vazquez C, Alvarez-fernandez M (2014) Influence of age on the clinical manifestations of invasive pneumococcal disease and antibiotic resistance rates. Med Clin (Barc) 143(7):287\u2013292","journal-title":"Med Clin (Barc)"},{"issue":"10","key":"5114_CR57","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.eimc.2017.10.022","volume":"36","author":"M Santana Hernandez","year":"2018","unstructured":"Santana Hernandez M, Aguiar-Santana IA, Artiles Campelo F, Colino Gil E (2018) Paediatric invasive pneumococcal disease on the island of Gran Canaria: 16-year prospective study (2001\u20132016). Enferm Infecc Microbiol Clin 36(10):607\u2013611","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"5114_CR58","doi-asserted-by":"crossref","unstructured":"Fenoll A, Ardanuy C, Linares J, Cercenado E, Marco F, Fleites A, Rodriguez-Mayo M, Lopez-Hontangas JL, Palop B, Aller AI, Buendia B, Mendez C, Cifuentes I (2018) Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study. Vaccine 36 (52):7993\u20138000","DOI":"10.1016\/j.vaccine.2018.10.098"},{"issue":"12","key":"5114_CR59","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10096-006-0225-9","volume":"25","author":"E Lahti","year":"2006","unstructured":"Lahti E, Mertsola J, Kontiokari T, Eerola E, Ruuskanen O, Jalava J (2006) Pneumolysin polymerase chain reaction for diagnosis of pneumococcal pneumonia and empyema in children. Eur J Clin Microbiol Infect Dis 25(12):783\u2013789","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"5114_CR60","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3201\/eid1409.071094","volume":"14","author":"I Obando","year":"2008","unstructured":"Obando I, Munoz-Almagro C, Arroyo LA, Tarrago D, Sanchez-Tatay D, Moreno-Perez D, Dhillon SS, Esteva C, Hernandez-Bou S, Garcia-Garcia JJ, Hausdorff WP, Brueggemann AB (2008) Pediatric parapneumonic empyema. Spain Emerg Infect Dis 14(9):1390\u20131397","journal-title":"Spain Emerg Infect Dis"},{"issue":"1","key":"5114_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/INF.0000000000001709","volume":"37","author":"LJ Ricketson","year":"2018","unstructured":"Ricketson LJ, Conradi NG, Vanderkooi OG, Kellner JD (2018) Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children Before and After the Seven-valent and Thirteen-valent Pneumococcal Conjugate Vaccine Programs in Calgary. Canada Pediatr Infect Dis J 37(1):22\u201327","journal-title":"Canada Pediatr Infect Dis J"},{"issue":"9","key":"5114_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001517","volume":"10","author":"DR Feikin","year":"2013","unstructured":"Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O\u2019Brien KL, Moore MR (2013) Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 10(9):e1001517","journal-title":"PLoS Med"},{"issue":"2","key":"5114_CR63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/21645515.2015.1057671","volume":"12","author":"GL Rodgers","year":"2016","unstructured":"Rodgers GL, Klugman KP (2016) Surveillance of the impact of pneumococcal conjugate vaccines in developing countries. Hum Vaccin Immunother 12(2):417\u2013420","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"5114_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177113","volume":"12","author":"E Balsells","year":"2017","unstructured":"Balsells E, Guillot L, Nair H, Kyaw MH (2017) Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis. PLoS ONE 12(5):e0177113","journal-title":"PLoS ONE"},{"key":"5114_CR65","doi-asserted-by":"crossref","unstructured":"Bennett JC, Hetrich MK, Garcia Quesada M, Sinkevitch JN, Deloria Knoll M, Feikin DR, Zeger SL, Kagucia EW, Cohen AL, Ampofo K, Brandileone MC, Bruden D, Camilli R, Castilla J, Chan G, Cook H, Cornick JE, Dagan R, Dalby T, Danis K, de Miguel S, De Wals P, Desmet S, Georgakopoulou T, Gilkison C, Grgic-Vitek M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, MacDonald L, Mackenzie GA, Mad'arov\u00e1 L, McGeer A, Mereckiene J, Morfeldt E, Mungun T, Mu\u00f1oz-Almagro C, Nuorti JP, Paragi M, Pilishvili T, Puentes R, Saha SK, Sahu Khan A, Savrasova L, Scott JA, Skoczy\u0144ska A, Suga S, van der Linden M, Verani JR, von Gottberg A, Winje BA, Yildirim I, Zerouali K, Hayford K (2021) Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project. Microorganisms 9 (4):696","DOI":"10.3390\/microorganisms9040696"},{"issue":"7","key":"5114_CR66","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s10096-011-1468-7","volume":"31","author":"L Selva","year":"2012","unstructured":"Selva L, Ciruela P, Esteva C, de Sevilla MF, Codina G, Hernandez S, Moraga F, Garc\u00eda-Garc\u00eda JJ, Planes A, Coll F, Jordan I, Carde\u00f1osa N, Batalla J, Salleras L, Dominguez A, Mu\u00f1oz-Almagro C (2012) Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR. Eur J Clin Microbiol Infect Dis 31(7):1487\u20131495","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05114-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05114-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05114-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:41:08Z","timestamp":1757169668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05114-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["5114"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05114-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MAF, MS, and KH are employees of Pfizer and may hold stock or stock options. OO and MB are employees of P95 Clinical &\u00a0Epidemiology Services, which received funding from Pfizer in connection with the development of this manuscript and the execution of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}